Haemonetics (HAE) Competitors $71.15 -0.87 (-1.21%) (As of 10/31/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends HAE vs. MMSI, XRAY, ICUI, NEOG, QDEL, STAA, OSUR, CERS, ANIK, and UTMDShould you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Merit Medical Systems (MMSI), DENTSPLY SIRONA (XRAY), ICU Medical (ICUI), Neogen (NEOG), QuidelOrtho (QDEL), STAAR Surgical (STAA), OraSure Technologies (OSUR), Cerus (CERS), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Haemonetics vs. Merit Medical Systems DENTSPLY SIRONA ICU Medical Neogen QuidelOrtho STAAR Surgical OraSure Technologies Cerus Anika Therapeutics Utah Medical Products Merit Medical Systems (NASDAQ:MMSI) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings. Is MMSI or HAE more profitable? Merit Medical Systems has a net margin of 9.02% compared to Haemonetics' net margin of 8.61%. Haemonetics' return on equity of 21.86% beat Merit Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Merit Medical Systems9.02% 15.29% 8.58% Haemonetics 8.61%21.86%9.04% Does the media favor MMSI or HAE? In the previous week, Merit Medical Systems had 23 more articles in the media than Haemonetics. MarketBeat recorded 27 mentions for Merit Medical Systems and 4 mentions for Haemonetics. Merit Medical Systems' average media sentiment score of 1.16 beat Haemonetics' score of 0.80 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 13 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in MMSI or HAE? 99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 3.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 1.8% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts recommend MMSI or HAE? Merit Medical Systems currently has a consensus target price of $103.36, indicating a potential upside of 3.80%. Haemonetics has a consensus target price of $106.14, indicating a potential upside of 48.45%. Given Haemonetics' higher possible upside, analysts plainly believe Haemonetics is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.92Haemonetics 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Does the MarketBeat Community favor MMSI or HAE? Merit Medical Systems received 43 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 69.34% of users gave Merit Medical Systems an outperform vote while only 61.07% of users gave Haemonetics an outperform vote. CompanyUnderperformOutperformMerit Medical SystemsOutperform Votes43269.34% Underperform Votes19130.66% HaemoneticsOutperform Votes38961.07% Underperform Votes24838.93% Which has more volatility & risk, MMSI or HAE? Merit Medical Systems has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500. Which has higher valuation & earnings, MMSI or HAE? Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerit Medical Systems$1.30B4.44$94.41M$1.7457.19Haemonetics$1.33B2.75$117.56M$2.2931.43 SummaryMerit Medical Systems beats Haemonetics on 12 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.>> Secure Your Spot On The Groundbreaking Workshop Here Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HAE vs. The Competition Export to ExcelMetricHaemoneticsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$3.67B$4.53B$5.37B$19.26BDividend YieldN/A43.24%5.21%3.52%P/E Ratio32.2732.75140.7331.45Price / Sales2.7567.861,437.0716.91Price / Cash12.3147.9838.9420.46Price / Book3.814.494.745.41Net Income$117.56M$13.97M$115.38M$984.71M7 Day Performance-5.00%1.35%-0.60%-0.06%1 Month Performance-10.42%1.28%3.92%-0.49%1 Year Performance-15.56%56.42%39.36%29.98% Haemonetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HAEHaemonetics4.8456 of 5 stars$71.15-1.2%$106.14+49.2%-15.2%$3.64B$1.33B31.913,657Upcoming EarningsMMSIMerit Medical Systems4.5638 of 5 stars$99.51+4.9%$103.00+3.5%+42.8%$5.78B$1.30B49.766,950Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageXRAYDENTSPLY SIRONA4.7434 of 5 stars$23.26-0.6%$32.67+40.4%-21.9%$4.72B$3.97B-27.0515,000Upcoming EarningsAnalyst UpgradeShort Interest ↓ICUIICU Medical4.0565 of 5 stars$172.45-1.7%$170.25-1.3%+78.2%$4.20B$2.30B-59.0614,000Upcoming EarningsPositive NewsNEOGNeogen2.5427 of 5 stars$14.40-1.2%$17.50+21.5%-3.3%$3.12B$912.20M-130.912,640Positive NewsQDELQuidelOrtho4.3904 of 5 stars$38.67-0.8%$58.83+52.1%-35.2%$2.60B$3.00B-1.397,100Upcoming EarningsNews CoverageSTAASTAAR Surgical4.8489 of 5 stars$28.50-3.4%$45.57+59.9%-28.0%$1.40B$332.94M83.821,115Analyst ForecastShort Interest ↓News CoverageGap UpOSUROraSure Technologies4.4925 of 5 stars$4.09-2.6%$6.67+63.0%-18.1%$304.98M$273.54M11.36638Upcoming EarningsCERSCerus2.7444 of 5 stars$1.65-4.4%$3.63+120.4%+31.3%$304.81M$169.98M-12.65625Gap UpANIKAnika Therapeutics4.2378 of 5 stars$16.59-32.8%$30.50+83.8%+30.0%$245.48M$166.88M-3.27357News CoverageGap DownHigh Trading VolumeUTMDUtah Medical Products3.9255 of 5 stars$63.91-0.2%N/A-19.0%$225.47M$46.58M14.76180Analyst UpgradeNews Coverage Related Companies and Tools Related Companies Merit Medical Systems Alternatives DENTSPLY SIRONA Alternatives ICU Medical Alternatives Neogen Alternatives QuidelOrtho Alternatives STAAR Surgical Alternatives OraSure Technologies Alternatives Cerus Alternatives Anika Therapeutics Alternatives Utah Medical Products Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HAE) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
